BILL · 2003–04 SESSION

HB 2035: Ephedrine & pseudoephedrine

Regarding the sale of ephedrine, pseudoephedrine, or phenylpropanolamine.

Summary

  • Provides that, to prevent violations of RCW 69.43.110, every licensee and registrant under chapter 18.64 RCW, who sells at retail any products containing ephedrine, pseudoephedrine, or phenylpropanolamine, or their salts, isomers, or salts of isomers, shall keep all such products behind the counter.

From the Bill Digest (HB 2035), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedFeb 20, 2003
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
John Ahern (R-6)
Introduced
February 20, 2003 in the House
Last action
January 12, 2004
Budget
Has a fiscal note

AN ACT Relating to the sale of ephedrine, pseudoephedrine, or phenylpropanolamine;

Sponsors

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. By resolution, reintroduced and retained in present status.
  3. By resolution, reintroduced and retained in present status.
  4. First reading, referred to Criminal Justice & Corrections.

HB 2035 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page